References
1. Klimko N., Kozlova Y., Khostelidi S. et al. The burden of serious fungal diseases in Russia. Mycose. 2015; 58 (suppl 5): 58-62.
2. GAFFI: Global Action Fund for Fungal Infections. URL: https://www.gaffi.org/
3. Cornely O.A., Lass-Flor C., Lagrou K., Arsic-Arsenijevic V., Hoenigl M. Improving outcome of fungal disease - guiding experts and patients towards excellence. Mycoses. 2017; 60: 420-5.
4. Vasilyeva N., Raush E., Bogomolova T.S., Shagdileeva E., Klimko N. Species distribution and susceptibility testing of Candida spp. isolated from patients with invasive candidosis in Russia. In: Mycoses. Special Issue: 7th Trends in Medical Mycology, 9-12 October 2015. Lisbon, Portugal. 2015; 58 (suppl S4): 149.
5. Munoz J.F., Gade L., Chow N.A., Loparev V.N., Juieng P., Farrer R.A., et al. Genomic basis of multidrug-resistance, mating, and virulence in Candida auris and related emerging species. Nat Commun. 2018; 9 (1): 5346.
6. Lu P.L., Liu W.L., Lo H.J., Wang F.D., Ko W.C., Hsueh P.R., et al. Are we ready for the global emergence of multidrug-resistant Candida auris in Taiwan? J Formos Med Assoc. 2017; 117: 462-70.
7. Jeffery-Smith A., Taori S.K., Schelenz S., et al. Candida auris: a review of the literature. Clin Microbiol Rev. 2017; 31 (1): e00029-17.
8. Riat A., Neofytos D., Coste A., et al. First case of Candida auris in Switzerland: discussion about preventive strategies. Swiss Med Wkly. 2018; 148: w14622.
9. Chowdhary A., Sharma C., Meis J.F. Candida auris: a rapidly emerging cause of hospital-acquired multidrug-resistant fungal infections globally. PLoS Pathogens. 2017; 13 (5): e1006290.
10. Lockhart S.R., Etienne K.A., Vallabhaneni S., Farooqi J., Chowdhary A., Govender N.P., et al. Simultaneous emergence of multidrug-resistant Candida auris on 3 continents confirmed by whole-genome sequencing and epidemiological analyses. Clin Infect Dis. 2017; 64 (2): 134-40.
11. Sekyere J.O. Candida auris: a systematic review and meta-analysis of current updates on an emerging multidrug-resistant pathogen. Microbiol Open. 2018; 7: e578.
12. Cortegiani A., Misseri G., Fasciana T., Giammanco A., Giarratano A., Chowdhary A. Epidemiology, clinical characteristics, resistance, and treatment of infections by Candida auris. J Intensive Care. 2018; 6 (69): 1-13.
13. Vasilyeva N.V., Pchelin I.M., Ryabinin I.A., Raush E.R., Chilina G.A., Bogomolova T.S.. et al. The first Russian case of candidaemia due to Candida auris. 28th ECCMID. 2018.
14. Chatterjee S., Alampalli S.V., Nageshan R.K., Chettiar S.T., Joshi S., Tatu U.S. Draft genome of a commonly misdiagnosed multidrug resistant pathogen Candida auris. BMC Genomics. 2015; 16: 686.
15. Pchelin I.M., Zlatogursky V.V., Rudneva M.V., et al. Reconstruction of phylogenetic relationships in dermatomycete genus Trichophyton Malmsten 1848 based on ribosomal internal transcribed spacer region, partial 28S rRNA and beta-tubulin genes sequences. Mycoses. 2016; 59: 566-75.
16. Pchelin I.M., Azarov D.V., Churina M.A., Scherbak S.G., Apalko S.V., Vasilyeva N.V., et al. Species boundaries in the Trichophyton mentag-rophytes/T. interdigitale species complex. Med Mycol. 2018; 57 (6): 781-9. DOI: 10.1093/mmy/myy115.
17. Kaas R.S., Leekitcharoenphon P., Aarestrup F.M., Lund 0. Solving the problem of comparing whole bacterial genomes across different sequencing platforms. PLoS One. 2014; 9 (8): e104984.
18. Cowen L.E., Sanglard D., Howard S.J., Rogers P.D., Perlin D.S. Mechanisms of antifungal drug resistance. Cold Spring Harb Perspect Med. 2014; 5 (7): a019752.
19. Morio F., Jensen R.H., Le Pape P., Arendrup M.C. Molecular basis of antifungal drug resistance in yeasts. Int J Antimicrob Agents. 2017; 50 (5): 599-606.
20. Hargrove T.Y., Friggeri L., Wawrzak Z., Qi A., Hoekstra W.J., Schotz-inger R.J., et al. Structural analyses of Candida albicans sterol 14a-demethy-lase complexed with azole drugs address the molecular basis of azole-mediated inhibition of fungal sterol biosynthesis. J Biol Chem. 2017; 292 (16): 6728-43.
21. Healey K.R., Kordalewska M., Jimenez Ortigosa C., Singh A., Berrfo I., Chowdhary A., et al. Limited ERG11 mutations identified in isolates of Candida auris directly contribute to reduced azole susceptibility. Antimicrob Agents Chemother. 2018; 62 (10): e01427-18.
22. Prasad R., Goffeau A. Yeast ATP-binding cassette transporters conferring multidrugresistance. Annu Rev Microbiol. 2012; 66: 39-63.